Evidence map›Paper›PMID 11687605›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

A novel Rtg2p activity regulates nitrogen catabolism in yeast.

M M Pierce, M L Maddelein, B T Roberts, R B Wickner

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M M PierceLaboratory of Biochemistry and Genetics, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Building 8, Room 225, 8 Center Drive MSC0830, Bethesda, MD 20892-0830, USA.
M L Maddelein
B T Roberts
R B Wickner

Funding

PRIONS OF YEASTZ01DK024943 · NIDDK · DIABETES, DIGESTIVE, KIDNEY DISEASES · PI WICKNER, REED B. · 1994 to 2006
–
6 · The paper itself

Abstract

The inactivity of Ure2p, caused by either a ure2 mutation or the presence of the [URE3] prion, increases DAL5 transcription and thus enables Saccharomyces cerevisiae to take up ureidosuccinate (USA+). Rtg2p regulates transcription of glutamate-repressible genes by facilitation of the nuclear entry of the Rtg1 and Rtg3 proteins. We find that rtg2 Delta cells take up USA even without the presence of [URE3]. Thus, the USA+ phenotype of rtg2 Delta strains is not the result generation of the [URE3] prion but is a regulatory effect. Because rtg1 Delta or rtg3 Delta mutations or the presence of glutamate do not produce the USA+ phenotype, this is a novel function of Rtg2p. The USA+ phenotype of rtg2 Delta strains depends on GLN3, is caused by overexpression of DAL5, and is blocked by mks1 Delta, but not by overexpression of Ure2p. These characteristics suggest that Rtg2p acts in the upstream part of the nitrogen catabolism regulation pathway.

Indexed as

Saccharomyces cerevisiae ProteinsBase SequenceDNA PrimersEpistasis, GeneticFungal ProteinsGenes, FungalIntracellular Signaling Peptides and ProteinsMutationNitrogenPhenotypeSaccharomyces cerevisiaeTranscription, GeneticDNA PrimersFungal ProteinsIntracellular Signaling Peptides and ProteinsNitrogenRTG2 protein, S cerevisiaeSaccharomyces cerevisiae Proteins

Identifiers

PMID11687605
PMCPMC60850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.